With 2.65 million shares changed hands, the volume of the stock remained lighter than its average volume of 2.75 million shares. The 52-week range on DOCS shows that it touched its highest point at $85.21 and its lowest point at $25.00 during that stretch. It currently has a 1-year price target of $61.56. Beta for the stock currently stands at 1.34.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of DOCS was down-trending over the past week, with a drop of -12.30%, but this was down by -5.46% over a month. Three-month performance dropped to -29.17% while six-month performance fell -1.82%. The stock gained 77.00% in the past year, while it has lost -3.99% so far this year. A look at the trailing 12-month EPS for DOCS yields 1.11 with Next year EPS estimates of 1.58. For the next quarter, that number is 0.30. This implies an EPS growth rate of 0.00% for this year and 11.19% for next year. EPS is expected to grow by 7.94% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 79.45%.
Float and Shares Shorts:
At present, 137.78 million DOCS shares are outstanding with a float of 133.10 million shares on hand for trading.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for DOCS since 5 analysts follow the stock currently. There are 3 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 2 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of $0.90775 being high and $0.87815 being low. For DOCS, this leads to a yearly average estimate of $0.89788. Based on analyst estimates, the high estimate for the next quarter is $0.45 and the low estimate is $0.3. The average estimate for the next quarter is thus $0.35.
